# Bridge to Life and Tevosol merge to commercialize organ preservation technology

Bridge to Life, a supplier of organ preservation solutions, and Tevosol, a medical device startup, announced their merger to develop and commercialize Tevosol's portable ex-vivo lung perfusion machine and normothermic organ preservation platform. The merger was announced on February 9, 2021.

- Type: Acquisition
- Announced: 2021-02-09
- Where: United States
- Status: completed
- Products: portable ex-vivo lung perfusion machine, normothermic organ preservation platform
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Bridge to Life](https://endata.com/companies/53131.md) (acquirer)
- [Tevosol](https://endata.com/companies/53132.md) (target)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/bridge-to-life-and-tevosol-merge-to-commercialize-portable-normothermic-machine-preservation-technology-platform-for-organ-transplantation-301225086.html), 2021-02-09: "Together we can fulfill the great promise of this emerging clinical practice—and we're already working on exciting projects beyond lung transplantation and a host of other possibilities for the future."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.